These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 11095452

  • 21. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, Riccardi G.
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Lipoprotein subfraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin.
    Billingham MS, Milles JJ, Bailey CJ, Hall RA.
    Metabolism; 1989 Sep; 38(9):850-7. PubMed ID: 2671598
    [Abstract] [Full Text] [Related]

  • 24. The lipoprotein profile differs during insulin treatment alone and combination therapy with insulin and sulphonylureas in patients with Type 2 diabetes mellitus.
    Lindström T, Nyström FH, Olsson AG, Ottosson AM, Arnqvist HJ.
    Diabet Med; 1999 Oct; 16(10):820-6. PubMed ID: 10547208
    [Abstract] [Full Text] [Related]

  • 25. Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes.
    Dullaart RP, de Vries R, Kwakernaak AJ, Perton F, Dallinga-Thie GM.
    Eur J Clin Invest; 2015 Jan; 45(1):36-44. PubMed ID: 25402623
    [Abstract] [Full Text] [Related]

  • 26. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
    Nikkilä EA, Huttunen JK, Ehnholm C.
    Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.
    Chappuis B, Braun M, Stettler C, Allemann S, Diem P, Lumb PJ, Wierzbicki AS, James R, Christ ER.
    Diabetes Metab Res Rev; 2007 Jul; 23(5):392-9. PubMed ID: 17211855
    [Abstract] [Full Text] [Related]

  • 30. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.
    Bavirti S, Ghanaat F, Tayek JA.
    Endocr Pract; 2003 Jul; 9(6):487-93. PubMed ID: 14715475
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of insulin on cholesterol synthesis in type II diabetes patients.
    Scoppola A, Testa G, Frontoni S, Maddaloni E, Gambardella S, Menzinger G, Lala A.
    Diabetes Care; 1995 Oct; 18(10):1362-9. PubMed ID: 8721938
    [Abstract] [Full Text] [Related]

  • 35. Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation.
    Rivellese A, Riccardi G, Romano G, Giacco R, Patti L, Marotta G, Annuzzi G, Mancini M.
    Diabetologia; 1988 Dec; 31(12):884-8. PubMed ID: 3240843
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The effect of a dual combination of noninsulin antidiabetic drugs on lipids: a systematic review and network meta-analysis.
    Dai X, Wang H, Jing Z, Fu P.
    Curr Med Res Opin; 2014 Sep; 30(9):1777-86. PubMed ID: 24805140
    [Abstract] [Full Text] [Related]

  • 39. Plasma lipoproteins and incidence of non-insulin-dependent diabetes mellitus in Pima Indians: protective effect of HDL cholesterol in women.
    Fagot-Campagna A, Narayan KM, Hanson RL, Imperatore G, Howard BV, Nelson RG, Pettitt DJ, Knowler WC.
    Atherosclerosis; 1997 Jan 03; 128(1):113-9. PubMed ID: 9051204
    [Abstract] [Full Text] [Related]

  • 40. The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients.
    Juntti-Berggren L, Pigon J, Karpe F, Hamsten A, Gutniak M, Vignati L, Efendic S.
    Diabetes Care; 1996 Nov 03; 19(11):1200-6. PubMed ID: 8908380
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.